ReviewNeurochemical research1998
Gangliosides and glycosphingolipids of peripheral nervous system myelins--a minireview.
Review in Neurochemical research, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 75 citations in OpenAlex.
- Molecular Mediators Associated With Myelination, Demyelination, and Remyelination in the Peripheral Nervous System.Journal of the peripheral nervous system : JPNS · 2026Review
- Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers.International journal of molecular sciences · 2024Review
- Regulatory mechanism for the human glioblastoma cell-specific expression of the human GD1c/GT1a/GQ1b synthase (hST8Sia V) gene.Glycoconjugate journal · 2023Article
- The role of gangliosides in the organisation of the node of Ranvier examined in glycosyltransferase transgenic mice.Journal of anatomy · 2022Review
- Mouse TRPA1 function and membrane localization are modulated by direct interactions with cholesterol.eLife · 2019Article
- The glycointeractome of serogroup B Neisseria meningitidis strain MC58.Scientific reports · 2017Article
- Sphingolipids in obesity and related complications.Frontiers in bioscience (Landmark edition) · 2017Review
- The node of Ranvier in multifocal motor neuropathy.Journal of clinical immunology · 2014Review
- Neuronal expression of GalNAc transferase is sufficient to prevent the age-related neurodegenerative phenotype of complex ganglioside-deficient mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014Article
- Ceramide function in the brain: when a slight tilt is enough.Cellular and molecular life sciences : CMLS · 2013Review
- Shiga toxin binding to glycolipids and glycans.PloS one · 2012Article
- Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction.The Journal of physiology · 2009Review
- Pathogenesis and treatment of immune-mediated neuropathies.Therapeutic advances in neurological disorders · 2009Article
- Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.Biochemistry · 2009Article
- A hypothesis about the relationship of myelin-associated glycoprotein's function in myelinated axons to its capacity to inhibit neurite outgrowth.Neurochemical research · 2009Review
- A highly efficient construction of GM1 epitope tetrasaccharide and its conjugation with KLH.Glycoconjugate journal · 2008Article
- Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.Archives of disease in childhood · 2007Article
- Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth.Proceedings of the National Academy of Sciences of the United States of America · 2005Article
- Ganglioside expression in tissues of mice lacking beta2-microglobulin.Clinical and experimental immunology · 2002Article
- Regulation of sulfoglucuronyl glycolipid synthesis in the developing rat sciatic nerve.Neurochemical research · 2001Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A summary is provided of the available data on the composition of gangliosides and glycosphingolipids in the peripheral nervous system (PNS) including myelins and their antigenic properties. The composition of gangliosides and glycosphingolipids in the PNS is very different from that in the central nervous system (CNS), both quantitatively and qualitatively. One major difference is the abundance of neolacto-series gangliosides in the PNS, with the backbone structure Gal beta 1-4GlcNAc beta1-3Gal beta 1-4Glc1-1'Cer. Their abundance contrasts with the abundance of ganglio-series gangliosides in the CNS. The neolacto-series gangliosides are localized mainly in the myelins of the PNS. In addition to gangliosides, other acidic and neutral glycosphingolipids in the neolactoseries are also characteristic of the myelins of the PNS. The ceramide (fatty acid and sphingosine base) compositions of gangliosides in the PNS are different from those in the CNS gangliosides, having greater percentages of long-chain fatty acids and dehydrosphingosines than found in the CNS gangliosides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.